Dr. Chelsea Aubrey Janik, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 488 W State Highway 71, Bastrop, TX 78602 Phone: 512-321-1020 |
Mrs. Tracie Poe Kadura, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 N Hasler Blvd, Bastrop, TX 78602 Phone: 512-581-7044 Fax: 512-332-0422 |
Dr. Trevor Dennis Holmes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1671 Highway 71 E, Bastrop, TX 78602 Phone: 512-308-0234 |
Debra Ann Thomas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 488 Highway 71 W, Bastrop, TX 78602 Phone: 512-321-1020 Fax: 512-321-4673 |
Kyoung Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 State Hwy 71 W, Bastrop, TX 78602 Phone: 512-321-4008 |
Michelle Truong Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 Highway 71 E, Bastrop, TX 78602 Phone: 512-308-1239 |
Sheryl Ann Kosler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 N Hasler Blvd, Bastrop, TX 78602 Phone: 512-321-1033 Fax: 512-332-0422 |
Jacquelyn Ann May, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 W Hwy 71, Bastrop, TX 78602 Phone: 512-321-4008 Fax: 512-321-2608 |
Dr. Jason Michael Aradanas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 Highway 71 W, Bastrop, TX 78602 Phone: 512-321-4008 |
Kristen Michelle Merwin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 N Hasler Blvd, Bastrop, TX 78602 Phone: 512-321-1033 Fax: 512-332-0422 |
Anna Slavinsky, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 State Highway 71 W, Bastrop, TX 78602 Phone: 512-321-4008 |
Kimberly Roxann Otto Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 N Hasler Blvd, Bastrop, TX 78602 Phone: 512-581-7044 Fax: 512-332-0422 |
Mrs. Kristi Louise Anderle, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 N Hasler Blvd, Bastrop, TX 78602 Phone: 512-321-1033 |
Dan White Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 West Highway 71, Bastrop, TX 78602 Phone: 512-321-4008 Fax: 512-321-2608 |
Edward Castillo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 488 Highway 71 W, Bastrop, TX 78602 Phone: 512-321-1020 |
Lisa Nicole Calliham Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1009 Pecan St, Bastrop, TX 78602 Phone: 512-791-3003 |
Dr. Tracey Ortega, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 Highway 71 W, Bastrop, TX 78602 Phone: 512-321-4008 |
Christopher Jason Lowe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 N Hasler Blvd, Bastrop, TX 78602 Phone: 512-321-1033 Fax: 512-332-0422 |
Michael Feller Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 Highway 71 E, Bastrop, TX 78602 Phone: 512-308-1082 |
Jamil Wehbe Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1671 Highway 71 E, Bastrop, TX 78602 Phone: 512-308-0234 |
News Archive
Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).
The H1N1 flu pandemic in 2009 underscored weaknesses in methods widely used to diagnose the flu, from frequent false negatives to long wait times for results. Now Boston University researchers have developed a prototype of a rapid, low-cost, accurate, point-of-care device that promises to provide clinicians with an effective tool to quickly diagnose both seasonal and pandemic strains of influenza, and thus limit the spread of infection.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.
The Environmental Inorganic Chemistry and Ceramic Materials Group of the Universitat Jaume I (UJI) in Castellón, Spain, has developed a research project to assess, transfer and exploit refreshing and photo-catalytic pigments (cool pigments) with a base of Scheelite that are used to decrease the temperature of buildings and also to absorb part of the environmental pollution.
› Verified 8 days ago